13F Data
13F filer · CIK 1832108

ABG-WTT Global Life Science Capital Partners GP Ltd

CENTRAL, HONG KONG, K3 · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$8.6M
$-3.7M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $3.2M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedCERIBELL INC-166,492-37.7%$-3.2M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $114.7MQ1 2021: $91.7MQ2 2021: $51.7MQ3 2021: $14.7MQ4 2021: $7.4MQ1 2022: $12.3MQ2 2022: $28.3MQ3 2022: $16.0MQ4 2022: $6.2MQ1 2023: $6.3MQ2 2023: $5.5MQ3 2023: $20.8MQ4 2023: $51.3MQ1 2024: $41.5MQ2 2024: $30.0MQ3 2024: $20.1MQ4 2024: $43.7MQ1 2025: $38.3MQ2 2025: $26.8MQ3 2025: $18.7MQ4 2025: $15.0MQ1 2026: $12.3MQ2 2026: $8.6M
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1CERIBELL INCCOM275,328$5.4M62.61%
2RAPID MICRO BIOSYSTEMS INCCLASS A COM1,848,296$3.2M37.39%